Introduction
Atraumatic osteonecrosis is a disease process that was originally described in 1925 as ischemic necrosis of the hip and since that time has had various names, including atraumatic necrosis, avascular necrosis, and idiopathic necrosis [26] . Although it can affect any joint, it most commonly occurs in the hip. Despite a poorly understood pathophysiology, it is known that patients in their third decade of life are at highest risk and that there is an annual prevalence of 10,000 to 20,000 new cases per year in the United States [47] . Left untreated, the natural history of the disease will progress to end-stage degenerative joint disease in greater than 80% of symptomatic cases and nearly two-thirds of asymptomatic ones [46, 47, 51] .
Treatment options have continued to evolve for osteonecrosis and include potential nonoperative pharmacotherapies (such as anticoagulants, bisphosphonates, shockwave therapy, or hyperbaric oxygen) [5, 6, 16, 17, 23, 24, 43, 52, 68] ; joint-preserving surgeries (core decompression and various vascularized and nonvascularized bone grafting procedures) [18, 35, 36] ; and joint-replacing surgeries, including THA. Although numerous treatment algorithms have been proposed to provide guidance to the treating physician [18, 19, 45, 58, 64] , controversy remains surrounding the most appropriate surgery and at what stage of the disease process these procedures should be performed [9, 10, 34, 50, 59, 60] .
In 2005, in an effort to better understand how the orthopaedic community treated this disease, the American Association of Hip and Knee Surgeons (AAHKS) conducted a study of their membership to determine the frequency of different procedures for the treatment of osteonecrosis of the femoral head [44] . The most frequently reported precollapse procedure was core decompression and the most frequently reported postcollapse procedure was THA. Because the reported incidence of THA has overall been increasing and projected to further increase in the coming decades [40] , the goal of the present study was to determine trends in the types and numbers of procedures performed for secondary, nontraumatic osteonecrosis of the femoral head from 1992 through 2008 in the United States based on data from the National Inpatient Sample (NIS). Because osteonecrosis is a disease that may be difficult to treat, and has many different treatment options, the authors wanted to assess how treatment trends have changed since 1992 given advances in surgical implants, surgical techniques for osteonecrosis as well as to assess the practicing physician's understanding of the efficacy of these treatments.
We therefore asked the following questions: (1) How has the overall incidence of surgical treatment changed over this time period; and (2) how has the percentage of THAs performed for osteonecrosis (compared with jointpreserving procedures) changed over this time period?
Patients and Methods
The NIS is a database maintained by the Agency for Healthcare Research and Quality and contains a longitudinal representative 20% sample of hospitals in the United States, tracking nearly 8 million hospitalizations per year [3] . All discharge records and information are cataloged each year and are subsequently stratified according to region, location, teaching status, and number of beds. For example, the NIS now contains data from 1051 hospitals located in 45 states. This represents a 20% stratified sample of all US hospitals from which sampling weights can be used to statistically estimate valid national totals. Review of this publicly available data set is exempt from review by our institutional review board.
All patients who had an International Classification of Diseases, 9
th Revision diagnosis of osteonecrosis of the hip The various procedure codes were then collated according to yearly frequency between 1992 and 2008, and trends were analyzed for joint-preserving and jointreplacing procedures. Core decompression, nonvascular bone grafting, free vascularized fibular graft, angular or rotational osteotomy, and limited femoral head resurfacing were considered joint-preserving procedures. Only THA was considered a joint-replacing procedure.
To answer the first question regarding the change in the overall incidence of surgical treatment of osteonecrosis, the total number of discharge records that was coded as an admission for osteonecrosis of the hip and had an associated procedure code listed here was collected. These records were then collated by year to evaluate the generalized trend in the total number of surgical cases performed to treat osteonecrosis between 1992 and 2008.
To answer the second question, regarding the percentage of joint-preserving procedures performed for osteonecrosis relative to the total number of osteonecrosis procedures performed, the same records were stratified based on whether the procedure was joint-preserving or jointreplacing, as detailed previously. Furthermore, the various types of joint-preserving procedures that were performed were analyzed to determine if there was a change in preferences for treating early stages of the disease.
Data analysis was carried out using JMP 8.2 statistical software (SAS Institute, Cary, NC, USA). To account for the stratified sampling used in the NIS database, weighted analysis was performed. Fisher's exact test was used to compare proportional differences between various groups. Probability values of \ 0.05 were considered significant for all analyses.
Results
The total number of procedures performed over this time period for osteonecrosis of the femoral head increased from 3570 procedures to 6400 procedures per year (Fig. 1) , nearly doubling over a 16-year time period (p \ 0.001).
In 1992, 76% (n = 2678) of the procedures performed to treat osteonecrosis of the hip were THA. This increased to 88% (n = 5632 in 2008 (p \ 0.001; Figs. 2, 3) . The percentage of joint-preserving procedures consequently decreased from 25% to 12% over this same time period (p \ 0.001; Fig. 3 ). The percentage of joint-preserving procedures as a fraction of total procedures decreased overall over the study period (Fig. 4) .
Discussion
Osteonecrosis is a potentially devastating disease with multiple treatment options and controversy both about the timing and the type of surgical intervention. Although some interventions have fallen from favor (at least in the United States) such as partial joint arthroplasty [2, 7, 8, 13, 63] and osteotomy [31, 53, 57, 66] , other joint-preserving interventions remain in use, and THA also is an option. In an effort to better understand and characterize the evolution and distribution of the types of procedures performed in the United States between the years 1992 and 2008 for osteonecrosis of the hip, the NIS was used to assess the change in overall surgical treatment incidence as well as the breakdown of specific procedures performed during that time period. Such an analysis is important because many physicians will see only small numbers of patients with osteonecrosis and may not have extensive experience treating the disease. Consequently, the authors aimed to assess the prevalence of treatment options in an effort to better understand the practicing community's understanding and preference in treating osteonecrosis.
There are several limitations to this study. Early precollapse disease is much less morbid than end-stage postcollapse disease, and it is not possible to distinguish the stage of the disease at the time of presentation based on the NIS database. Consequently, it is impossible to interpret if total joint arthroplasties are being performed on early-or late-stage lesions. If this were the case, it is possible that early precollapse lesions may have been treated with jointreplacing procedures rather than a more appropriate jointpreserving procedure. Similarly, there may be a number of patients who may not have been coded as osteonecrosis, but rather osteoarthritis if the patient may have had end-stage degenerative joint disease subsequent to osteonecrosis. This would increase the percentage and incidence of THA if higher numbers of these patients were included in the analysis. It is interesting to note that in 1999 there was an acute decrease in procedures reported in the NIS. Although the NIS is a longitudinal database, it is constantly expanded. This may reflect a change in the number of hospitals or a change in types of practices that were represented at various hospitals in the NIS. Another limitation is that age was not compared between treatment types in this analysis. Because younger patients may place higher demands on their implants, it may be of interest to see if there was a difference in age between treatment types. Future studies could assess this to determine whether age plays a factor in the treatment algorithm. Despite these limitations, we believe the results of this study effectively demonstrate the trends of the practice community in their treatment of this difficult disease, which in turn may be a reflection of the understanding of treatment options and their efficacy.
Previously, THA had poor reported survivorship and clinical results for the treatment of osteonecrosis of the hip. However, reports since 1993 have suggested improved outcomes in patients with osteonecrosis with survivorship reportedly improving from as low as 38% before 1993 [1, 12, 27, 48, 60, 62] to most studies reporting survivorship greater than 80% since 1993 [4, 9, 11, 14, 15, 20-22, 25, 28-30, 32, 33, 37-39, 41, 42, 49, 54-56, 61, 65, 67, 69-72] . The trends reported in this study may suggest that providers have taken heed of this and are using THA more frequently. Additionally, although the percentage of jointpreserving procedures has decreased, the total number of procedures (such as core decompression and bone grafting procedures) has increased. This suggests that despite a lower percentage, the number of patients who receive a joint-preserving procedure and may not require an arthroplasty has increased. We found an increased percentage of cases performed for osteonecrosis were joint-replacing procedures. An earlier study [39] surveyed surgeons in the AAHKS to ascertain their preferred surgical procedures based on the Steinberg classification system [64] . That study, which had a response rate of 53% (403 of 760), found that core decompression was the preferred treatment option for symptomatic precollapse lesions (Steinberg Stages IB and IIB), and THA was the preferred treatment option for postcollapse lesions (Steinberg Stages IIIB, IVB, V, and VI). Although the present study, which was based on NIS values, was able to assess trends in treatment options, it could not provide insight into each surgeon's decisionmaking based on the stage of the disease. However, one may conclude that the most prevalent procedure, overall, for the treatment of osteonecrosis of the femoral head between 1992 and 2008 was THA and that the most prevalent joint-sparing procedure was core decompression. It is possible that this reported effect may have been the result of the complexity of the alternative joint-sparing procedures (grafting or osteotomy procedures) coupled with improved outcomes of primary THA in patients who have osteonecrosis.
Regardless of the type of surgery, either joint-preserving or joint-replacing, the trends reported in this study indicate an overall increase in the number of procedures performed for osteonecrosis of the femoral head. This may reflect an improved awareness of this disease, more aggressive approaches to diagnosis and treatment (including more frequent use of THA), improved access to health care, technological improvements, or improved treatment for early, precollapse lesions. This study provided insight into the preferred treatment options of the orthopaedic community, which is important to know, especially for conditions such as osteonecrosis that have numerous classification algorithms as well as a variety of treatment options, some of which may be technically challenging. Future studies are necessary to assess the current prevalence of the disease among the general population to better characterize these findings. It is important to recognize that this study was purely descriptive. As such, we do not recommend that all patients who have osteonecrosis be treated with THA; individualized approaches to treatment, based on age, stage of disease, and surgeon experience, are most appropriate as are continuing research into new biological and mechanical joint-preserving technologies that may provide additional conservative treatment options to the patient who has osteonecrosis.
